GCN2 inhibitors and uses thereof
US10988477B2 · kind B2 · utility
3Cited by
15References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 28, 2019 |
| Grant date | Apr 27, 2021 |
| Priority date | — |
| Expiry date | Feb 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds inhibiting General amino acid Control Non-derepressible 2 kinase (“GCN2”), compositions thereof, and methods of using the same for treating various disorders, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.